These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23263472)

  • 1. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
    Vrenken H; Jenkinson M; Horsfield MA; Battaglini M; van Schijndel RA; Rostrup E; Geurts JJ; Fisher E; Zijdenbos A; Ashburner J; Miller DH; Filippi M; Fazekas F; Rovaris M; Rovira A; Barkhof F; de Stefano N;
    J Neurol; 2013 Oct; 260(10):2458-71. PubMed ID: 23263472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach.
    Valverde S; Cabezas M; Roura E; González-Villà S; Pareto D; Vilanova JC; Ramió-Torrentà L; Rovira À; Oliver A; Lladó X
    Neuroimage; 2017 Jul; 155():159-168. PubMed ID: 28435096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
    Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.
    Dell'Oglio E; Ceccarelli A; Glanz BI; Healy BC; Tauhid S; Arora A; Saravanan N; Bruha MJ; Vartanian AV; Dupuy SL; Benedict RHB; Bakshi R; Neema M
    J Neuroimaging; 2015; 25(2):191-199. PubMed ID: 25523616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.
    Durand-Dubief F; Belaroussi B; Armspach JP; Dufour M; Roggerone S; Vukusic S; Hannoun S; Sappey-Marinier D; Confavreux C; Cotton F
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1918-24. PubMed ID: 22790248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
    Lazeron RH; Boringa JB; Schouten M; Uitdehaag BM; Bergers E; Lindeboom J; Eikelenboom MI; Scheltens PH; Barkhof F; Polman CH
    Mult Scler; 2005 Oct; 11(5):524-31. PubMed ID: 16193889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the effects of white matter multiple sclerosis lesions on the volume estimation of 6 brain tissue segmentation methods.
    Valverde S; Oliver A; Díez Y; Cabezas M; Vilanova JC; Ramió-Torrentà L; Rovira À; Lladó X
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1109-15. PubMed ID: 25678478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
    Pareto D; Sastre-Garriga J; Aymerich FX; Auger C; Tintoré M; Montalban X; Rovira A
    Neuroradiology; 2016 May; 58(5):467-74. PubMed ID: 26847633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of whole-brain atrophy in multiple sclerosis.
    Pelletier D; Garrison K; Henry R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring individual multiple sclerosis lesion volume change over time: Development of an algorithm for the analyses of longitudinal quantitative MRI measures.
    Köhler C; Wahl H; Ziemssen T; Linn J; Kitzler HH
    Neuroimage Clin; 2019; 21():101623. PubMed ID: 30545687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.
    Moccia M; Prados F; Filippi M; Rocca MA; Valsasina P; Brownlee WJ; Zecca C; Gallo A; Rovira A; Gass A; Palace J; Lukas C; Vrenken H; Ourselin S; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Barkhof F;
    Ann Neurol; 2019 Nov; 86(5):704-713. PubMed ID: 31385358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy.
    Taylor I; Butzkueven H; Litewka L; MacGregor LR; Szoeke C; Cook M; Mitchell P; Kilpatrick TJ; Tubridy N
    J Clin Neurosci; 2004 Feb; 11(2):153-8. PubMed ID: 14732374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
    Khalid F; Healy BC; Dupuy SL; Chu R; Chitnis T; Bakshi R; Houtchens M
    J Neurol Sci; 2018 Sep; 392():94-99. PubMed ID: 30031994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects.
    Weeda MM; Middelkoop SM; Steenwijk MD; Daams M; Amiri H; Brouwer I; Killestein J; Uitdehaag BMJ; Dekker I; Lukas C; Bellenberg B; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2019; 24():101962. PubMed ID: 31416017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
    Rocca MA; Valsasina P; Damjanovic D; Horsfield MA; Mesaros S; Stosic-Opincal T; Drulovic J; Filippi M
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):35-41. PubMed ID: 23064100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
    Chua AS; Egorova S; Anderson MC; Polgar-Turcsanyi M; Chitnis T; Weiner HL; Guttmann CR; Bakshi R; Healy BC
    Neuroimage Clin; 2015; 8():606-10. PubMed ID: 26199872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
    Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.